AASLD News

AASLD Governance Election Update

AASLD is pleased to announce the election of new Governing Board and Foundation Board members who will begin their terms in January 2022. The 2021 Nominating Committee met on April 6, 2021 and selected finalists for the positions of Councilor, Secretary, Foundation Board Trustee, Councilor-at-Large and members of the 2022 Nominating Committee.

AASLD Remembers Roberto Groszmann, MD, FRCP

The American Association for the Study of Liver Diseases acknowledges the passing of one of its members who made major contributions to our field. Roberto Groszmann, MD, FRCP passed away in New Haven on January 16, 2021.

UDCA Treatment Lowers Biliary Tract Cancer, Need for Liver Transplantation in PSC Patients

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that ursodeoxycholic acid (UDCA) treatment has significant, positive results for patients with primary sclerosing cholangitis (PSC), including

Unique Coagulation Driven By IL-6 Trans-Signaling Associated With Liver Injury In COVID-19

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that COVID-19 coagulation impairment, driven in part by endothelial Factor VIII, is associated with liver injury in infected patients.

New Cases Of Hepatocellular Carcinoma Disproportionately Affecting Americans In Rural Areas New Study Shows

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the rate of new hepatocellular carcinoma (HCC) cases has slowed since 2009, but only in urban areas.

Alarming New Study Highlights Need For Improved Access To HBV Vaccination, Testing And Treatment

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that in 2019, more than 500,000 persons died of hepatitis B virus infection, highlighting the urgent need for universal HBV vaccination of children beginning at birth, and scaling up testing and access to care and treatment before people with

More Women Diagnosed With HCV During Pregnancy, but Many Infants Still Not Tested Despite Recommendations From Leading Health Organizations

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases (AASLD)– found that among pregnant women with hepatitis C virus (HCV), more than 25 percent were initially diagnosed during pregnancy screenings, which

High Abdominal Fat And Low Liver Fat Combo Increases Coronary Heart Disease Risk

Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the distribution of a person’s body fat affects coronary heart disease risk, with an increased risk of heart events among people with a combination of high visceral adipose tissue (VAT) – abdominal fat─ and low liver fat.

Cirrhosis in North American Women on the Rise, Trend Especially Worrisome in Young Women

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org ALEXANDRIA, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that the burden of cirrhosis in women in North America has increased substantially in recent years, a worrying trend driven by a rise in alcohol

Affordable Care Act’s Medicaid Expansion Improves Liver Transplant Waitlist Placement, Especially for Certain Minorities

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that U.S. states that took part in the Affordable Care Act’s Medicaid expansion, which extended health care coverage to more low-income citizens

New Machine Learning-Based Model More Accurately Predicts Liver Transplant Waitlist Mortality

Media Contact: Caroline Laurin Phone: (703) 299-9766 Email: media@aasld.org Alexandria, VA – Data from a new study presented this week at The Liver Meeting Digital Experience® – held by the American Association for the Study of Liver Diseases – found that using neural networks, a type of machine learning algorithm, is a more accurate model for predicting waitlist mortality in liver transplantation

AASLD's Newest Open-Access Journal To Receive First Impact Factor

Today the American Association for the Study of Liver Diseases (AASLD) announced that Hepatology Communications – AASLD’s free, open-access journal – has been accepted into Clarivate’s Science Citation Index Expanded (SCIE) and Journal Citation Reports – one of the leading citation indexes for journals of science and technology. The journal will now be eligible for an Impact Factor (IF) evaluation

AASLD President's Statement On 2020 Nobel Prize In Medicine

Join me and the AASLD in congratulating Drs. Harvey J. Alter, Michael Houghton, and Charles M. Rice, the 2020 recipients of the Nobel Prize in Physiology for Medicine. Their groundbreaking research identified the Hepatitis C virus (HCV) – a bloodborne pathogen that causes acute and chronic hepatitis, cirrhosis, and liver cancer – and laid the foundation for the future development of a cure.

AASLD Foundation Announces Funding of Over $2.2 Million in Research and Career Development Awards, Abstract Awards, and Emerging Liver Scholars Program

Alexandria, VA – The American Association for the Study of Liver Diseases (AASLD) Foundation, the largest private supporter of liver disease research and training in the United States, today announced its combined investment of over $2.2 million in Research and Career Development Awards, Abstract Awards, and its Emerging Liver Scholars (ELS) Program. The 2020 award recipients — selected from a